REGNRegeneron Pharmaceuticals IncQ2 2026Jul 30, 2026, 6:30 AM EDT
REGN logo
Earnings Report· 2026-07-30

REGN

Q2 · 2026Pre-Market
Regeneron Pharmaceuticals Inc
EARNING PER SHARE
Actual ($)
14.29
11.00% YoY
Expected
10.21
Beat
+39.96%
REVENUE
Actual ($)
4.29B
17.00% YoY
Expected
3.82B
Beat
+12.32%